Gegenanzeigen · Silapo
Silapo 1 000 IU/0.3 mL solution for injection in pre-filled syringe Silapo 2 000 IU/0.6 mL solution for injection in pre-filled syringe Silapo 3 000 IU/0.9 mL solution for injection in pre-filled syringe Silapo 4 000 IU/0.4 mL solution for injection in pre-filled syringe Silapo 5 000 IU/0.5 mL solution for injection in pre-filled syringe Silapo 6 000 IU/0.6 mL solution for injection in pre-filled syringe Silapo 8 000 IU/0.8 mL solution for injection in pre-filled syringe Silapo 10 000 IU/1 mL solution for injection in pre-filled syringe Silapo 20 000 IU/0.5 mL solution for injection in pre-filled syringe Silapo 30 000 IU/0.75 mL solution for injection in pre-filled syringe Silapo 40 000 IU/1 mL solution for injection in pre-filled syringe · Abschnitt 4.3 · PDF-Seite 10
HOS-117524 · Präparat HOS-094633
All contraindications associated with autologous blood predonation programmes should be respected in patients being supplemented with Silapo.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-23T01:00:00Z · SHA-256 b64bab2695f111765204ca0695c8777dd4fde4f211eddcb7966b87838f8157cb · Passage 01906ff59669efabb3c00788777a9977090bf6e78b672043b11ea406cd68d90b · Zeichen 320–461 im Abschnitt